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Iontophoretic injections of the fluorescent retrograde tract tracer, Fluoro-gold, into the entopeduncular nucleus of the rat (homologous to the 
internal segment of the primate globus pallidus) resulted in a substantial number of retrogradely labeled neurons in the ipsilateral globus pallidus 
(homologous to the external segment of the primate globus pallidus). In experiments confirming this projection, iontophoretic injections of the anter- 
ograde tract tracer, Phaseolus vulgaris-leucoagglutinin, in the globus pallidus resulted in dense fiber and terminal labeling in the ipsilateral entopedun- 
cular nucleus. This projection is topographically organized in rostral-caudal, medial-lateral and dorsal-ventral orientations. 
Previous experimental research utilizing degeneration 
methods in primates noted the presence of a projection 
from the external segment of the globus pallidus to the 
internal segment of the globus paUidus in some reports 
[8, 20] but failed to note it in others [1, 9]. Nauta and 
Mehler [10] described terminal degeneration in the pri- 
mate internal globus paUidus following a lesion re- 
stricted to the external globus pallidus (case MGB 12), 
but stated that this may have been due to the interrup- 
tion of striatofugal fibers. Recently Hazrati et al. [6] 
reported evidence for this projection in primate using 
Phaseolus vulgaris-leucoagglutinin (PHA-L) as a tract 
tracer. Similarly, the experimental literature on connec- 
tions between the globus pallidus (GP) and the entope- 
duncular nucleus (EP) of the rodent provides prelimi- 
nary evidence of their existence, but no description of the 
organization of the system. Carter and Fibiger [2] 
injected [3H]leucine in the rodent GP and noted the pres- 
ence of grains over the EP, but were unable to determine 
whether these represented axons of passage or terminals. 
Other suggestive evidence for this projection comes from 
Smith and Bolam [18] and Shu and Peterson [17] who 
identified the presence of anterogradely labeled fibers in 
the EP following injections of PHA-L in the rodent GP 
while studying other projection targets of the GP, and 
from Staines [19] who reported preliminary evidence for 
a GP to EP projection. Physiological evidence for this 
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projection has been reported by Kitai and Kita [7] who 
recorded antidromic activation of GP neurons with 
intracellular electrodes after stimulation of EP. 
The objectives of this study were to investigate the 
existence of a projection from the GP to the EP using 
complementary modern neuroanatomical methods and 
to describe the organization of this projection. 
Adult Sprague-Dawley rats (212--484 g; Harlan, Por- 
tage MI) were anesthetized with either chloral hydrate 
(400 mg/kg, i.p.) or ketamine/xylazine (10/3 ratio, 1.0 
ml/kg, i.p.) prior to placement in a stereotaxic frame. 
The following injection coordinates were taken from the 
rat atlas by Paxinos and Watson [13], for EP: AP, -2 .3  
to -3 .3  mm; ML, -2 .5  to -3 .2  mm; DV, -7 .4  to 
-7 .7  mm from bregrna; for GP: AP, -1 .0  mm; ML, 
- 3 . 4  to - 3 . 6  mm; DV, - 6 . 0  to -6 .5  mm from 
bregrna. To eliminate the possibility of tracer leakage 
into the caudate-putamen (CPu), 5 of the GP injections 
were made at a 16 ° angle from the midsagittal plane with 
ML and DV coordinates adjusted to - 1 . 0  mm and 
- 7 . 0  to -7 .5  mm respectively, the pipette trajectory 
thus avoiding the CPu. 
Fluoro-gold (FG; Fluoro-chromes, Englewood, CO; 
2.5% in acetic acid, pH 2.9) was iontophoretically 
injected (1.5-3.0 gA, 7 s on 7 s off, for 5-16 min) into 
the EP of 16 adult rats via glass micropipettes with inside 
tip diameters of 20--45 gm. Following a survival time of 
4-7 days the animals were perfused with 200 ml of 0.1 
M sodium phosphate buffered saline (PBS) with 0.1% 
sodium nitrite followed by 300-400 ml of 4% parafor- 
maldehyde in 0.1 M phosphate buffer (PB). The brains 
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were postfixed for 1-2 h and cryoprotected in 20% su- 
crose in PB overnight.  Frozen coronal  or sagittal sections 
(40/zm) were collected in PB with 0.1% sodium azide. 
The sections were moun ted  on gel-subbed slides, dehy- 
drated in graded alcohols to xylene and  coverslipped in 
DPX (Gallard-Schlesinger,  Carle Place, NY). 
Sections not  further than 120/~m apart  were analyzed 
on either a Leitz Aris toplan or Or thoplan  microscope 
equipped with epifluorescence. A filter block providing 
ultraviolet excitation was used to visualize F G  labeled 
neurons.  
P H A - L  (2.5% in PBS, pH 8.0; Vector, Burlingame, 
Fig. 1. FG injection sites produced retrogradely labeled neurons indicating the medial/lateral topography of projection from GP to EP. A: FG 
injection site centered in lateral EP with minimal spread of tracer into surrounding structures. B: FG injection site centered in medial EP with spread 
into the lateral hypothalamus. C: FG labeled neurons restricted to the lateral part of the ipsilateral GP following the injection shown in A. D: 
FG labeled neurons restricted to the medial part of the ipsilateral GP following the injection shown in B. Asterisks mark the boundary between 
the GP and CPu. CPu, caudate putamen; EP, entopeduncular nucleus; GP, globus pallidus; IC, internal capsule; OT, optic tract. Bar = 400 ~tm 
in A and B, and 27511m in C and D. 
CA) was iontophoretically injected (5 gA, 7 s on 7 s off, 
12-20 min) into the GP of 10 adult rats via glass micro- 
pipettes with inside tip diameters of 15-30 gm. Ten days 
later the animals were perfused with 200 ml of PBS with 
0.1% sodium nitrite followed by 300-400 ml of 4% para- 
formaldehyde (n = 2) or 4% paraformaldehyde with 0.1% 
glutaraldehyde (n = 8) in PB. The brains were postfixed 
for 1-2 h in the fixative solution and cryoprotected over- 
night in 20% sucrose in PB. Frozen coronal or sagittal 
sections (40 gm) were stored in 0.02 M KPBS with 0.1% 
sodium azide until processed for PHA-L immunocyto- 
chemistry. The sections were washed twice before incu- 
bation in goat anti-PHA-L (Vector Labs; 1:1000 dilu- 
tion) for 48 h at 4°C on the rotator. The sections were 
washed 3 times, incubated with biotinylated rabbit anti- 
goat antibody (Vector Labs; 1:100 dilution) for 1 h at 
room temperture, then washed 3 times before incubation 
in the Vectastain Elite ABC solution (Vector Labs) for 
1 h at room temperture on the rotator. All washes were 
carried out in 0.02 M KPBS with 2% normal rabbit se- 
rum and 0.3% Triton X-100 until the wash preceding the 
ABC incubation; after that wash all steps were carried 
out in plain 0.02 M KPBS. 
All FG injection sites that included the EP resulted in 
retrogradely labeled neurons in the ipsilateral GP. Other 
areas that contained retrogradely labeled neurons in- 
cluded the CPu, the subthalamic nucleus (STh), the 
pedunculopontine tegmental nucleus and the substantia 
nigra (SN), all of which are known afferents of the EP 
[12]. Retrogradely labeled neurons and processes con- 
tained strongly fluorescent golden granules that filled the 
cell body and proximal processes. 
The FG animals were divided into groups according 
to the location of the center of the injection site and the 
extent of spread into surrounding structures. One group 
consisted of animals with injections confined to the EP 
(n = 5). The second group had injections centered in the 
most medial part of the EP which spread into the lateral 
hypothalamus (n=2). The third group had injections 
centered in the ventral EP with spread of tracer into the 
optic tract and the medial nucleus of the amygdala 
(n = 7). The fourth group of animals had injections cen- 
tered in the dorsal EP with spread of the tracer into the 
reticular nucleus of the thalamus (RT) and the zona 
incerta (n = 2). 
The iontophoretic sites restricted to EP demonstrated 
the existence of the GP-EP projection but did not pro- 
vide complete information as to the topography since 
they covered the whole extent of the nucleus in most ani- 
mals. One of these animals did provide information 
about the topographic organization of the projection. 
This injection site was almost completely confined to the 
lateral EP and resulted in retrogradely labeled neurons 
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primarily in the lateral part of GP (Fig. 1A,C). In the 
second group the injection sites were centered in the me- 
dial half of EP and resulted in retrogradely labeled neu- 
rons primarily in the medial half of GP (Fig. 1B,D). In 
the third and fourth groups the injections were limited 
to the ventral or dorsal parts of the nucleus and resulted 
in retrogradely labeled neurons primarily in the ventral 
or dorsal areas of the GP, respectively (Fig. 2). Rostral/ 
caudal topographic information was provided by injec- 
tions from all 4 groups of animals. Sites centered in 
either the rostral or caudal EP resulted in labeling of 
neurons primarily in the corresponding area of GP and 
suggested a topographic organization in this dimension 
as well. The large number of retrogradely labeled neu- 
rons in the GP following each injection of FG into the 
EP (Fig. 1C,D) suggested that this projection is quite 
extensive. 
All PHA-L injection sites that included the GP 
resulted in substantial anterograde labeling in the ipsila- 
teral EP. Many labeled fibers were noted to have en pas- 
sant varicosities and terminal boutons in the EP. Other 
structures that also contained anterogradely labeled 




Fig. 2. Schematic representation of the dorsal/ventral topography of 
the GP to EP projection. FG injections from two different animals that 
included only the dorsal (angled lines) or ventral (vertical lines) part 
of EP resulted in selective transport to the respective parts of GP. The 
two different rostral/caudal levels of GP correspond to the -0 .9  and 
- 1.3 AP levels in the atlas of Paxinos and Watson [13]. 
124 
Fig. 3. A: PHA-L injection site in the GP; the pipette was angled to avoid the CPu. B and C: anterogradely labeled fibers with boutons forming 
apparent terminals on the proximal dendrites and somata of  neurons (arrowheads) in the ipsilateral EP following the injection shown in A. B: note 
how the labeled fibers cover the soma of  an EP neuron. Bar = 800/~m in A, and 25/tm in B and C. 
the SN, all previously described as projection sites of the 
GP [12]. 
Of the 10 animals that received PHA-L injections, 5 
animals had injection sites confined to the GP (Fig. 3A). 
In two of these animals the pipette was angled to avoid 
the CPu, to avoid any leakage of tracer into this known 
afferent of the EP. The other injection sites included sur- 
rounding structures such as the CPu laterally (n = 4), or 
the RT medially (n = 1). 
Analysis of the injections restricted to the GP revealed 
dense anterograde labeling of fibers and terminals in the 
ipsilateral EP, even after relatively small injections (Fig. 
3A-C). The topography of the projection was indicated 
by injections that were limited to one part of the GP, and 
confirmed the organization suggested by the FG injec- 
tions. An injection limited to the medial or lateral GP 
resulted in anterogradely labeled fibers primarily in the 
corresponding part of the ipsilateral EP. 
The labeled fibers in the EP following the GP PHA-L 
injections were of two types. One type of fiber traveled 
between the fiber bundles that pierce the EP, coursing in 
the neuropil of the EP. These fibers had numerous vari- 
cosities, many of which surrounded the somata and the 
proximal dendrites of neurons in the EP (Fig. 3B,C). 
This pattern of fiber and terminal labeling, where the la- 
beled fibers form a 'basket' around the somata and prox- 
imal dendrites of EP neurons, is similar to that seen in 
the SN following injections of PHA-L in the rat GP, as 
reported by Smith and Bolam [18]. The second type of 
fiber was smooth shafted with no varicosities and was 
restricted to the fiber bundles that penetrate the EP. This 
type of fiber was likely a fiber of passage, probably pass- 
ing to caudal projection structures such as the STh or the 
SN. 
Evidence presented here indicates that the GP sends a 
substantial, topographically organized projection to the 
EP in the rat. Although either of the tract tracing meth- 
ods used in this study may provide false positive results 
via transport from damaged fibers of passage [3, 15, 16], 
we used experimental procedures designed to minimize 
damage at the injection site in both cases. Our FG injec- 
tions were made with a relatively dilute solution of 
tracer, using low currents for short periods of time. Our 
PHA-L injections were small, did not result in any ne- 
crosis at the injection site or abnormal retrograde or 
anterograde labeling that would indicate transport of the 
tracer by damaged fibers of passage. 
Results obtained using tritiated amino acid tract trac- 
ing, which is not subject to transport by fibers of passage 
[4], are consistent with our findings. Carter and Fibiger 
[2] reported the presence of silver grains over the EP fol- 
lowing injections of [3H]leucine into the rat GP, but 
could not determine if these were fibers of passage or ter- 
minals. Evidence presented here indicates that they were 
terminals and not fibers of passage. 
Although definitive proof of this projection awaits 
study at the ultrastructural level, previous studies have 
shown that PHA-L labeled fibers at the light microscopic 
level, similar in appearance to those seen in this study, 
represent synaptic contacts when analyzed with an elec- 
tron microscope [18, 21]. 
The existence of a direct projection from the GP to the 
EP would provide a route for disinhibition of EP neu- 
rons, as the GP receives an inhibitory projection from 
the CPu [5] and it has been shown that almost all GP 
neurons are GABAergic [11, 14]. 
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